CLASS III Drug recall · Reported 5 Dec 2018 · FDA Enforcement Report

Nitrofurantoin Monohydrate/Macrocrystals capsules,100 mg recalled

RemedyRepack is recalling Nitrofurantoin Monohydrate/Macrocrystals capsules,100 mg, distributed in Pennsylvania. The recall was initiated on 7 Nov 2018 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: B0484872-081718, B0481339-081018, Exp 08/2019; B0506246-092718, Exp 09/2019; B0509938-100418, Exp 10/2019
Quantity recalled3,148 capsules

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0284-2019
FDA event ID
81638
Recalling firm
RemedyRepack, Indiana, PA
Classification
Class III
Status
Terminated
Recall initiated
7 Nov 2018
FDA classified
27 Nov 2018
Reported
5 Dec 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material
Drug class
Antibiotics

Timeline

7 Nov 2018Recall initiated by company
27 Nov 2018Classified by FDA+20 days
5 Dec 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cross contamination with other products: Product is being recalled due to the potential presence of unrelated ingredients (Benazepril, Haloperidol and Perphenazine).

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Nitrofurantoin Monohydrate/Macrocrystals capsules,100 mg, packaged in HDPE 60 cc bottles, Rx only, MFG: Sandoz Inc., Princeton, NJ, Repackaged by: RemedyRepack, Indiana, PA, Original NDC 00185-0122-01Repackaged NDC 70518-1087-00, 14 capsules in HDPE 60 cc bottles in cardboard trays & HDPE 60 cc bottles in plastic bags, Repackaged NDC 70518-1087-01, 10 capsules in HDPE 60 cc bottles in cardboard trays.

Where it was distributed

Product was distributed to two medical facilities in Pennsylvania.

Pennsylvania

Questions about this recall

Why was it recalled?

Cross contamination with other products: Product is being recalled due to the potential presence of unrelated ingredients (Benazepril, Haloperidol and Perphenazine).

Which lots are affected?

Lot #: B0484872-081718, B0481339-081018, Exp 08/2019; B0506246-092718, Exp 09/2019; B0509938-100418, Exp 10/2019

Where was it sold?

Product was distributed to two medical facilities in Pennsylvania.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from RemedyRepack

All 61

Other Nitrofurantoin recalls

All 11